NCPA advises FDA on clearer and more accessible Patient Medication Information

NCPA recently submitted comments to the FDA on its proposed rule titled “Medication Guides: Patient Medication Information.” The proposed rule would require manufacturers to create a one-page document, called Patient Medication Information (PMI), that would replace the current Medication Guides, Patient Package Inserts and Consumer Medication Information that are distributed to patients.

Related Keywords

,Patient Medication Information ,Medication Guides ,Patient Package Inserts ,Consumer Medication Information ,